Description

This edition of the Genetic TOE depicts the current landscape and the new life sciences trends across cancer therapy. In particular, next generation cancer therapies, novel targets and genetic technologies, and personalized vaccines have been profiled. The corresponding patent scenario is depicted along with the industry interactions.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Cancer therapy, cancer targets, microRNA gene therapy, personalized vaccines